Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (5), 682-686
- https://doi.org/10.1016/0959-8049(94)90545-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Contrasting effects of 17 β‐estradiol on the growth of human ovarian carcinoma cells in vitro and in vivoInternational Journal of Cancer, 1993
- Mitogenic effects of epidermal growth factor and transforming growth factor-α on EGF-receptor positive human ovarian carcinoma cell linesEuropean Journal Of Cancer, 1992
- Estrogen and progesterone receptors in ovarian neoplasms: discrepant results of immunohistochemical and biochemical methodsInternational Journal of Gynecologic Cancer, 1991
- Therapeutic potential of pure antioestrogens in the treatment of breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cellsBritish Journal of Cancer, 1989
- Biology and mode of action of pure antioestrogensJournal of Steroid Biochemistry, 1988
- Tamoxifen in refractory ovarian cancer: the use of a loading dose scheduleBritish Journal of Cancer, 1988
- A phase II study of tamoxifen in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovaryInternational Journal of Cancer, 1980